Deals

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Boehringer continues kidney dealmaking with $120M Variant pact

Boehringer unveiled its second kidney-focused collab in recent weeks, this time penning a deal worth up to $120 million with genomics-focused Variant.
James Waldron Jan 6, 2026 10:45am
Various shades of blue sewing thread spools

Amgen weaves in UK biotech with up to $840M acquisition

Jan 6, 2026 10:35am
support

Roche commits $100M to keep its GLP-1 Structure sound

Jan 6, 2026 10:21am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly returns to Nimbus in $1.3B deal to create oral obesity med

Jan 6, 2026 10:05am
Businesswoman ripping up contract

Instil's stock sinks after it clears out clinical pipeline

Jan 6, 2026 8:50am
Old vintage retro golden compass on ancient map

Pfizer maps out $865M Cartography discovery deal

Jan 6, 2026 7:30am